Cleared Traditional

K252122 - DCwire Micro-guidewire (FDA 510(k) Clearance)

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K252122 · Shanghai Achieva Medical Suzhou Co., Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2026
Decision
252d
Days
Class 2
Risk

K252122 is an FDA 510(k) clearance for the DCwire Micro-guidewire. Classified as Guide, Wire, Catheter, Neurovasculature (product code MOF), Class II - Special Controls.

Submitted by Shanghai Achieva Medical Suzhou Co., Ltd. (Suzhou, CN). The FDA issued a Cleared decision on March 16, 2026 after a review of 252 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1330 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Shanghai Achieva Medical Suzhou Co., Ltd. devices

Submission Details

510(k) Number K252122 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 07, 2025
Decision Date March 16, 2026
Days to Decision 252 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
104d slower than avg
Panel avg: 148d · This submission: 252d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MOF Guide, Wire, Catheter, Neurovasculature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - MOF Guide, Wire, Catheter, Neurovasculature

All 39
Devices cleared under the same product code (MOF) and FDA review panel - the closest regulatory comparables to K252122.
Aristotle 14 Guidewire
K253579 · Scientia Vascular, Inc. · Apr 2026
Zenith Micro Guidewire
K252317 · Suzhou Zenith Vascular SciTech Limited · Apr 2026
Willow 24 Guidewire
K260537 · Arbor Endovascular, LLC · Mar 2026
Willow 18 Guidewire
K260130 · Arbor Endovascular, LLC · Feb 2026
CHIKAI Nexus petit
K252011 · Asahi Intecc Co., Ltd. · Feb 2026
0.014” Willow Guidewire
K253168 · Arbor Endovascular, LLC · Nov 2025